TelyRx Holdings Inc. (TSX:TELY)
Canada · Delayed Price · Currency is CAD | Market Cap | 117.73M |
| Revenue (ttm) | 77.31M +205,037.0% |
| Net Income | -14.05M |
| EPS | -1.30 |
| Shares Out | 48.85M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 2.450 |
| Previous Close | 2.450 |
| Day's Range | 2.450 - 2.450 |
| 52-Week Range | 2.000 - 4.250 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 11, 2026 |
About TelyRx Holdings
TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company which develops and operates a digital pharmacy platform. Its platform connects patients nationwide with physicians for access to everyday prescriptions. The company also operates pharmacies which ship the medicine to the patient's door with next-day delivery. It caters to doctors, veterinarians, practice groups, and other licensed prescribers. The company is based in Clearwater, Florida. [Read more]
Financial Performance
In 2025, TelyRx Holdings's revenue was $42.92 million, an increase of 350.27% compared to the previous year's $9.53 million. Losses were -$5.43 million, -59.76% less than in 2024.
Financial numbers in USD Financial StatementsNews
TelyRx Announces Voting Results from Annual General Meeting of Shareholders
Clearwater, Florida--(Newsfile Corp. - June 15, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy...
TelyRx Surpasses 1 Million Prescriptions, Underscoring Growing Demand for Digital Pharmacy
Milestone reflects strong customer response to simpler, more convenient access to essential healthcare Clearwater, Florida--(Newsfile Corp. - June 8, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: T...
TelyRx Commences Trading on the OTCQX Market in the United States
Clearwater, Florida--(Newsfile Corp. - June 5, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy ...
TelyRx Holdings Transcript: Small Cap Growth Virtual Investor Conference
A digital pharmacy platform has achieved rapid growth by offering over 450 everyday medications with same-day delivery, transparent pricing, and no insurance required, targeting the $98 billion cash-pay market. With $43 million in 2025 revenue, strong repeat customer rates, and scalable operations, it is positioned for continued expansion and margin improvement.
TelyRx Holdings Transcript: Transcript
Q1 2026 revenue surged 180% year-over-year to $19.4M, with prescriptions filled up 188%. Gross margin improved to 55%, and management expects to achieve over $100M in 2026 revenue, with positive EBITDA for the year.
TelyRx Holdings Slides: Investor presentation
TelyRx Holdings has posted slides in relation to its latest quarterly earnings report, which was published on May 13, 2026.